Plasma YKL-40 has been determined in a large prospective cohort study of 8899 subjects (aged 20–95 years) from the Danish general population, the Copenhagen City Heart Study, followed for 11 years for cancer incidence and for 14 years for death. Here, CHI3L1 is linked to cancer.